Literature DB >> 12667955

Long-term (1 year) functional and histological results of autologous skeletal muscle cells transplantation in rat.

Nawwar Al Attar1, Claire Carrion, Said Ghostine, Isabelle Garcin, Jean-Thomas Vilquin, Albert A Hagège, Philippe Menasché.   

Abstract

BACKGROUND: Several studies have demonstrated the short-term benefits of autologous skeletal muscle cell transplantation on postinfarction left ventricular function. The present experiments were designed to assess the long-term effects of the procedure. METHODS AND
RESULTS: Thirteen Wistar rats that had undergone skeletal muscle cell transplantation (n=6) or injection of control culture medium (n=7) in isoforms areas after myocardial infarction created by coronary artery ligation and survived for 1 year were functionally assessed by combining echocardiography and pressure-volume loops. At 1 year after transplantation, both contractile and relaxation indices were significantly improved in the skeletal muscle cell-grafted group compared with controls. One-year echocardiographic measurements of ejection fraction were similar to those recorded 2 months after the procedure. The stability of the functional outcome contrasted with a decrease in the number of histologically detectable skeletal myotubes over time. However, the proportion of the slow and composite (fast and slow) myosin isoforms expressed by skeletal muscle fibers still present after 1 year was greater than that found in animals sacrificed after 2 months.
CONCLUSION: The functional benefits of autologous skeletal muscle cell transplantation are sustained over time and are associated with either selection, preservation or an increased expression of slow myosin heavy chain isoforms. The discrepancy between maintenance of this improvement and the decay in the engrafted myotubes suggests protective mechanisms operative from the early post-transplantation stage and possibly involving modulation of extracellular matrix remodelling or paracrinally induced maturation of putative cardiac resident stem cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12667955     DOI: 10.1016/s0008-6363(02)00790-3

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  13 in total

Review 1.  Stem cells and cardiac repair: a critical analysis.

Authors:  Jonathan H Dinsmore; Nabil Dib
Journal:  J Cardiovasc Transl Res       Date:  2008-01-31       Impact factor: 4.132

Review 2.  Cardiac stem cell therapy and arrhythmogenicity: prometheus and the arrows of Apollo and Artemis.

Authors:  Alexander R Lyon; Sian E Harding; Nicholas S Peters
Journal:  J Cardiovasc Transl Res       Date:  2008-07-16       Impact factor: 4.132

3.  Non-invasive analysis of myoblast transplants in rodent cardiac muscle.

Authors:  Kevin S Cahill; Sean Germain; Barry J Byrne; Glenn A Walter
Journal:  Int J Cardiovasc Imaging       Date:  2004-12       Impact factor: 2.357

4.  Correlations between microRNAs and their target genes in skeletal myoblasts cell therapy for myocardial infarction.

Authors:  Andrea Rognoni; Chiara Cavallino; Francesco Rametta; Angelo Sante Bongo
Journal:  Ann Transl Med       Date:  2016-08

Review 5.  Therapeutic approaches for cardiac regeneration and repair.

Authors:  Hisayuki Hashimoto; Eric N Olson; Rhonda Bassel-Duby
Journal:  Nat Rev Cardiol       Date:  2018-10       Impact factor: 32.419

6.  The small molecule Chicago Sky Blue promotes heart repair following myocardial infarction in mice.

Authors:  Oren Yifa; Karen Weisinger; Elad Bassat; Hanjun Li; David Kain; Haim Barr; Noga Kozer; Alexander Genzelinakh; Dana Rajchman; Tamar Eigler; Kfir Baruch Umansky; Daria Lendengolts; Ori Brener; Nenad Bursac; Eldad Tzahor
Journal:  JCI Insight       Date:  2019-11-14

Review 7.  Skeletal myoblasts for cardiac repair.

Authors:  Shazia Durrani; Mikhail Konoplyannikov; Muhammad Ashraf; Khawaja Husnain Haider
Journal:  Regen Med       Date:  2010-11       Impact factor: 3.806

Review 8.  Cardiac repair with adult bone marrow-derived cells: the clinical evidence.

Authors:  Buddhadeb Dawn; Ahmed Abdel-Latif; Santosh K Sanganalmath; Michael P Flaherty; Ewa K Zuba-Surma
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 9.  More Than Tiny Sacks: Stem Cell Exosomes as Cell-Free Modality for Cardiac Repair.

Authors:  Raj Kishore; Mohsin Khan
Journal:  Circ Res       Date:  2016-01-22       Impact factor: 17.367

10.  Impact of hepatocyte growth factor on skeletal myoblast transplantation late after myocardial infarction.

Authors:  Stacy B O'Blenes; Audrey W Li; Chris Bowen; Drew Debay; Mohammed Althobaiti; James Clarke
Journal:  Drug Target Insights       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.